Amgen reports a 22% increase in Q1 2024 net revenues

Amgen announced updates in the obesity space, with topline data for MariTide expected in late 2024.

May 7, 2024 - 00:00

Amgen reports a 22% increase in Q1 2024 net revenues

Amgen announced updates in the obesity space, with topline data for MariTide expected in late 2024.

Read the original article

Tags:

Previous Article

Sentynl acquires Eiger’s Zokinvy for progeria treatment

Regeneron and Lilly Struggle with Clinical Objectives after Market Focus on Weig...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Moderna’s mRNA influenza vaccine receives $176m boost

Moderna’s mRNA influenza vaccine receives $176m boost

Jul 4, 2024

Fulvestrant by Kashiv BioSciences for Metastatic Breast...

Nov 6, 2023

Republicans divided over financial crisis in Medicare

Republicans divided over financial crisis in Medicare

Nov 9, 2023